Aminoglycosides
- BP-S-6-Medicinal Chemistry III
- Mar 28
- 1 min read
Historical Background of Aminoglycosides
Aminoglycosides First discovered in 1944 (Streptomycin by Selman Waksman).
Used mainly for Gram-negative infections and tuberculosis.
Nomenclature
Contain amino sugars linked by glycosidic bonds.
Common names:
Streptomycin
Neomycin
Kanamycin
Stereochemistry
Multiple chiral centers in aminosugar moieties.
The specific orientation of hydroxyl and amino groups affects activity and bacterial binding.
Structure-Activity Relationship (SAR)
1,3-diaminoinositol core: Essential for ribosomal binding.
Aminosugar modifications:
Improve ribosome binding.
Influence resistance to modifying enzymes.
Hydroxyl and amine groups interact with rRNA, causing misreading of mRNA.
Chemical Degradation Classification
Oxidative degradation: Leads to inactive products.
Enzymatic modification: By bacterial enzymes (acetylation, phosphorylation).
Hydrolysis in acidic conditions.
Important Products
Streptomycin (first discovered, used for TB).
Gentamicin (broad-spectrum use).
Amikacin (resistant to aminoglycoside-modifying enzymes).
Neomycin (topical use).